GlassScriptPhysician profile
Nidhi Agrawal
NPI 1043625726
$11,166.39
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,127 · 2020: $1,579 · 2021: $2,010 · 2022: $49.75 · 2023: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385 · Travel and Lodging: $15.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.82 |
| Travel and Lodging | $15.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $6,227.19 | 2019-2023 | Senza |
| Boston Scientific Corporation | $2,116.38 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Mml US, INC. | $1,710.25 | 2021 | |
| Vertos Medical, INC. | $273.51 | 2019-2020 | |
| Medtronic USA, INC. | $237.12 | 2020 | |
| Abbott Laboratories | $143.25 | 2023 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.02 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $82.58 | 2019-2021 | |
| Medtronic, INC. | $53.07 | 2023 | Intellis Adaptivestim |
| Redhill Biopharma INC. | $45.65 | 2021 | |
| Ibsa Pharma INC. | $43.41 | 2021 | |
| Stryker Corporation | $31.96 | 2023 | Gamma |
| Biohaven Pharmaceuticals, INC. | $30.40 | 2021 | |
| Spr Therapeutics, INC | $26.58 | 2020 | |
| Horizon Therapeutics Plc | $11.90 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhi Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.